European Pharmaceutical Review

JULY 5, 2023

43: Identification and Classification of Nonconformities in Moulded and Tubular Glass Containers for Pharmaceutical Manufacturing. According the PDA, the standardised quality criteria in TR 43 are intended as a guidance overview for container manufacturers and for incoming container acceptance inspection at pharmaceutical companies.

Pharmaceutical Manufacturing 96

Pharmaceutical Manufacturing Packaging Documentation Pharmaceutical Companies 96

Express Pharma

MAY 6, 2024

The event brought together over 330 professionals from across the industry’s value chain Pharmaceutical Manufacturing and Packaging Congress (PHARMAP 2024) was held in Amsterdam, Netherlands on April 22-23, 2024. Among the attendees, contract manufacturing organisations, service providers and experts were present.

Packaging 102

Packaging Pharmaceutical Manufacturing Labelling Pharmaceutical Companies 102

Pharmaceutical Technology

MAY 9, 2023

The global pharmaceutical industry experienced a 114% rise in company filings mentions of environmental sustainability in Q1 2023 compared with the previous quarter, with the highest share accounted for by Novozymes with 27% year-on-year increase, according to GlobalData’s analysis of over 757 pharmaceutical company filings.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

OCTOBER 3, 2024

Indeed, a key aspect of EU GMP Annex 1 is the requirement for pharmaceutical manufacturers to develop a comprehensive Contamination Control Strategy (CCS) that documents their approach to assuring the sterile drug product’s high quality and, therefore, enhancing patient safety.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 52

Pharmaceutical Technology

MAY 9, 2023

The global pharmaceutical industry experienced a 141% rise in company filings mentions of corporate governance in Q1 2023 compared with the previous quarter, with the highest share accounted for by GSK with 306% year-on-year increase, according to GlobalData’s analysis of over 898 pharmaceutical company filings.

Pharmaceutical Manufacturing 45

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 45

European Pharmaceutical Review

JUNE 3, 2024

Implementation of lightweight and portable spectroscopic instruments has “opened up new avenues” for quality assurance and process monitoring in pharmaceutical manufacturing, according to the report. This enables pharmaceutical companies to monitor their manufacturing processes at various stages.

Pharmaceutical Manufacturing 97

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 97

European Pharmaceutical Review

JULY 18, 2023

Adoption of QMS within pharma and biopharma is increasing due to strict regulations, frequent changes in the manufacturing process and higher demand to increase production capacity. Some pharmaceutical companies are increasing their R&D spending to increase product numbers.

Documentation 98

Documentation Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 98

Pharmaceutical Technology

MAY 9, 2023

The global pharmaceutical industry experienced a 141% rise in company filings mentions of corporate governance in Q1 2023 compared with the previous quarter, with the highest share accounted for by GSK with 306% year-on-year increase, according to GlobalData’s analysis of over 898 pharmaceutical company filings.

Pharmaceutical Manufacturing 40

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 40

Pharmaceutical Technology

MAY 9, 2023

The global pharmaceutical industry experienced a 114% rise in company filings mentions of environmental sustainability in Q1 2023 compared with the previous quarter, with the highest share accounted for by Novozymes with 27% year-on-year increase, according to GlobalData’s analysis of over 757 pharmaceutical company filings.

Pharmaceutical Manufacturing 40

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 40

European Pharmaceutical Review

JUNE 10, 2024

The first industrial-scale pharmaceutical manufacturing facility for production of lead-212-based radioligand therapies has been inaugurated. Radioligand therapy developments in 2023 and 2024 Other companies making progress producing radioligand therapies include Novartis. billion.

Pharmaceutical Manufacturing 98

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 98

Express Pharma

NOVEMBER 21, 2024

This allows pharmaceutical companies to identify compliance trends and support negotiations with certainty. The enhancement is particularly significant for pharmaceutical manufacturers managing rebates and compliance across international markets, enabling standardisation and adherence to regulatory reporting standards.

59

59

Express Pharma

JUNE 1, 2024

Pharmaceutical companies face unique challenges due to their rapid digital transformation, adopting Internet of Things (IoT), Artificial Intelligence (AI), and blockchain technologies. Cybersecurity Challenges Intellectual Property Theft: Pharmaceutical companies invest heavily in research and development. With over 1.9

Pharmaceutical Companies 96

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Hospitals 96

Pharmaceutical Technology

MAY 23, 2023

With an increasing focus on ESG, Pharmaceutical companies are under pressure to incorporate sustainability with suppliers playing a crucial role in the process. Notably, the number of environmental sustainability-related patent applications in the pharmaceutical industry was 1,948 in Q1 2023, versus 2,528 in the prior quarter.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 52

European Pharmaceutical Review

OCTOBER 17, 2022

Sanofi has signed definitive agreements with Adragos Pharmaceutical, a German contract development and manufacturing organisation (CDMO), for the sale of its pharmaceutical manufacturing site in Kawagoe, Japan. The French pharmaceutical company will also enter into a long-term supply agreement with the CDMO.

Pharmaceutical Manufacturing 104

Pharmaceutical Manufacturing Packaging Diabetes Pharmaceutical Companies 104

European Pharmaceutical Review

AUGUST 31, 2023

[pharmaceutical companies] must take measures to manage antibiotic waste across the manufacturing supply chain” 2023 has so far, delivered a spectrum of change for antibiotic manufacturers across the pharmaceutical industry, from supply chain issues through to regulatory opportunities.

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Hospitals 97

Express Pharma

JUNE 14, 2024

The manufacturing process and cost structure of this sector make it a prime candidate for early inclusion in this form of climate action. With a similar rationale, large healthcare buyers (like global pharmaceutical companies, retailers, medical chains, etc.) Infections and diseases once easy to treat become dangerous.

Pharmaceutical Companies 107

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Packaging 107

European Pharmaceutical Review

JUNE 6, 2023

Standard for antibiotic manufacturing to help combat AMR … Following this “ground-breaking standard” stated Courtney Soulsby, BSI Global Director for Healthcare Sustainability, the certification will “promote responsible pharmaceutical manufacturing and help protect the natural environment and slow antimicrobial resistance”.

Pharmaceutical Manufacturing 98

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 98

PharmaState Academy

NOVEMBER 16, 2023

” The first panel at the Now & Next Summit featured prominent figures from top pharmaceutical companies. Additionally, digital technologies are crucial in quality management, supply chain, and product integrity within pharmaceutical manufacturing.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Communication 52

European Pharmaceutical Review

AUGUST 29, 2024

The innovative programme is set to strengthen clinical trials and improve medicine manufacturing in the UK. Additionally, further funding from pharmaceutical companies will help to establish the investment programme. Importantly, NHS patients will be able to access new treatments earlier.

Pharmaceutical Manufacturing 59

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 59

Pharmaceutical Technology

NOVEMBER 21, 2022

However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR). Other reasons include lower sales demand and high investment costs.

Drug Pricing 69

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 69

pharmaphorum

MARCH 22, 2021

The International Finance Corporation, the division of the World Bank Group that invests in the private sectors of emerging markets, has provided financing for several emerging market pharmaceutical manufacturers with the goal of boosting developing countries’ access to affordably priced drugs. About the author. Dr Subir K.

Vaccines 122

Vaccines Pharmaceutical Manufacturing Dosage Pharmaceutical Companies 122

Express Pharma

JUNE 5, 2024

Also, the proliferation of antimicrobial resistance (AMR), where overuse of antibiotics leads to resistant bacteria, making infections harder to treat Additionally, pharmaceutical manufacturing consumes substantial amounts of solvents, which are typically highly toxic chemicals, as well as heavy metals.

Pharmaceutical Manufacturing 95

Pharmaceutical Manufacturing Packaging Documentation Compounding 95

Pharmaceutical Technology

NOVEMBER 21, 2022

However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR). Other reasons include lower sales demand and high investment costs.

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 52

FDA Law Blog: Biosimilars

MARCH 6, 2024

His practice supports clients throughout the life sciences from biotech startups and multinational pharmaceutical companies to CROs and academic researchers to patient advocacy organizations.

Pharmaceutical Manufacturing 57

Pharmaceutical Manufacturing Drug Development Pharmaceutical Companies Pharmaceutical Companies 57

European Pharmaceutical Review

JULY 12, 2022

Microbes developing resistance to disinfectants is a major emerging problem in pharmaceutical manufacturing cleanrooms and, if left unchecked, could present a threat to drug quality and, therefore, human health.

Pharmaceutical Manufacturing 111

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 111

Pharmaceutical Technology

SEPTEMBER 5, 2022

Pharmaceutical wholesalers act as intermediaries between pharmaceutical manufacturers and retailers and facilitate the delivery of the right medicines in a timely, efficient, and secure manner. Wholesale distributors are responsible for guaranteeing product quality and preventing the influx of counterfeited drugs.

Documentation 52

Documentation Packaging Labelling Pharmaceutical Manufacturing 52

pharmaphorum

DECEMBER 28, 2022

So, how do smaller pharmaceutical companies at the cutting edge get ready for their acquisition milestone, so they maximise their value and attractiveness? Any purchasing company would ideally like to integrate their acquisitions into their company seamlessly.

Pharmaceutical Manufacturing 119

Pharmaceutical Manufacturing Documentation Pharmaceutical Companies Pharmaceutical Companies 119

Pharmaceutical Technology

SEPTEMBER 20, 2022

Contract marketing companies support pharmaceutical companies in creating, improving, and maintaining their brand, as well as reducing risk, and ensuring better product placement in the market. Identifying the top commercial dose (non-sterile) companies in contract marketing.

Documentation 52

Documentation Pharmaceutical Manufacturing Packaging Pharmaceutical Companies 52

Pharmaceutical Technology

SEPTEMBER 14, 2022

Commercial dose companies form a critical component of the pharmaceutical manufacturing industry’s value chain. The dose form manufacturing follows API manufacturing to produce the final dosage form (FDF such as tablets and injectables.

Dosage 40

Dosage Pharmaceutical Manufacturing Documentation Pharmaceutical Companies 40

European Pharmaceutical Review

SEPTEMBER 29, 2022

The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme.

Nursing Homes 97

Nursing Homes Pharmaceutical Manufacturing Department of Veterans Affairs Dosage 97

European Pharmaceutical Review

APRIL 18, 2024

What are the three main challenges of monitoring pharmaceuticals in the environment? Andreas Häner (AH): Roche, along with other pharmaceutical companies, acknowledges concerns about pharmaceuticals in the environment (PiE).

Pharmaceutical Manufacturing 97

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 97

Pharmaceutical Technology

SEPTEMBER 15, 2022

The pharmaceutical industry requires specialised and cost-effective commercial packaging solutions to improve efficiency and preserve the integrity of products through the entire supply chain, from primary packaging and labelling to shipping, delivery, storage and distribution to end users.

Packaging 52

Packaging Labelling Pharmaceutical Manufacturing Documentation 52

Viseven

JANUARY 13, 2023

So what do exactly HEOR experts do for the pharmaceutical companies and what HEOR-collected data is used for? HEOR collects all reports about health outcomes from patients and physicians and later provides detailed analytics to healthcare providers, clinical outcomes research institutions or pharmaceutical companies.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Dosage Drug Pricing 40

Express Pharma

APRIL 20, 2023

COVID-19 has sped up the digital transformation and forced pharmaceutical companies to rethink many aspects of their business. Continuous manufacturing The topic of continuous manufacturing is also discussed in frames of PHARMAP 2023. This leads to growth in the pharma industry by finding new solutions and innovations.

Packaging 52

Packaging Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

MARCH 15, 2024

He mentions that OPPI member companies follow the stringent OPPI Code of Pharmaceutical Practices 2019 (OPPI Code) which is based on the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Code.

Pharmaceutical Manufacturing 104

Pharmaceutical Manufacturing Communication Pharmaceutical Companies Pharmaceutical Companies 104

European Pharmaceutical Review

NOVEMBER 8, 2022

3) policing anticompetitive settlements between competing drug manufacturers. European pharmaceutical companies targeting the US market should be aware of these pending bills and their potential impacts on market entry, intellectual property enforcement and payer access. 5) monitoring access to biosimilars.

Biosimilars 52

Biosimilars Drug Pricing Pharmaceutical Manufacturing Pharmaceutical Companies 52

Express Pharma

AUGUST 13, 2024

With growing awareness of the environmental impact of pharmaceutical manufacturing—such as pollution from toxic discharges—companies must adopt more sustainable practices. One of the primary challenges the industry faces is the inherent resource intensity of pharmaceutical manufacturing.

Pharmaceutical Manufacturing 64

Pharmaceutical Manufacturing Packaging Biosimilars Pharmaceutical Companies 64